Vect-Horus Enters Exclusive License Agreement with Novo Nordisk to Develop Targeted Therapeutics
MARSEILLE, France, October 30, 2023--Vect-Horus announced it has entered into a global license agreement with Novo Nordisk A/S.
Stay updated with breaking news from Global Research Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MARSEILLE, France, October 30, 2023--Vect-Horus announced it has entered into a global license agreement with Novo Nordisk A/S.
BOSTON, July 11, 2023 /PRNewswire/ -- Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, today announced the completion of the pilot phase of their...
BOSTON, April 19, 2023 /PRNewswire/ -- Today, Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, is hosting its annual conference, Ferment. The conference... | April 19, 2023
/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced a collaboration with Novo Nordisk, a leading...
GuruFocus Article or News written by GuruFocusNews and the topic is about: